Cargando…
FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
SIMPLE SUMMARY: Factors such as estrogen, progesterone, and androgen receptors, also known as nuclear receptors, are abundantly expressed in the majority of breast cancers where they serve as critical regulators of tumor growth and metastatic disease. The ability of these receptors to regulate breas...
Autores principales: | Seachrist, Darcie D., Anstine, Lindsey J., Keri, Ruth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533709/ https://www.ncbi.nlm.nih.gov/pubmed/34680352 http://dx.doi.org/10.3390/cancers13205205 |
Ejemplares similares
-
Up to your NEK2 in CIN
por: Seachrist, Darcie D., et al.
Publicado: (2021) -
TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters
por: Webb, Bryan M., et al.
Publicado: (2021) -
KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene
por: Roberts, Melyssa S., et al.
Publicado: (2020) -
Pioneer of prostate cancer: past, present and the future of FOXA1
por: Teng, Mona, et al.
Publicado: (2020) -
Pioneer Factors FOXA1 and FOXA2 Assist Selective Glucocorticoid Receptor Signaling in Human Endometrial Cells
por: Whirledge, Shannon, et al.
Publicado: (2017)